Westmead Dermatology Striving towards disease-free skin
At the 23rd World Congress of Dermatology, A/Prof Pablo Fernandez-Peñas gave a lecture in the International Classification of Diseases (ICD) workshop. A small group of Dermatologists are developing or helping to develop the Dermatology chapter of the new version (11) of the ICD (The Dermatology Topic Advisory Group (TAG)). This WHO project is supported by …
Written by Dr Shelley Ji Eun Hwang High Risk Melanoma Clinic is currently recruiting patients in Westmead Hospital. If the patient meets the following inclusion criteria (any of these): 2 x primary invasive melanomas 1 x primary invasive melanoma + Family history (≥ 3 first or second degree relatives) 1 x primary invasive melanoma + …
We are delighted that he results of the Oral Nicotinamide To Reduce Actinic Cancer (ONTRAC) are now public. We have shown that Nicotinamide decreases the number of skin cancers (basal cell carcinoma and squamous cell carcinoma) in high risk patients. Westmead Dermatology is one of the two sites that participated in the Clinical Trial, Bonita …
The Chronic Eczema clinic has been developed by Associate Professor Pablo Fernández-Peñas to treat patients struggling with the treatment of eczema. The clinic is open to adults, adolescents and children who are struggling with this condition. This clinic will give patients an opportunity for very comprehensive treatment planning and advice, also involving an educational component …
Mass Spectrometry or MS is one of the advanced techniques that is used to systematically study and examine a large number of proteins in a cell, tissue or an organism. Recently, with advancement in the area of cutting edge proteomic technology, MS has become the primary tool for differential proteomic analyses, identification of protein biomarkers …
Written by Dr Shelley Hwang (Westmead Dermatology Research Associate) One of the research projects that we are currently conducting in Westmead Research Dermatology includes a cohort study on the topic anti-PD1. Anti-PD1 is an immunotherapy that is currently under clinical trials for metastatic oncology patients. This is often used in metastatic melanoma patients when the …
Our high risk melanoma clinic has recruited 21 patients till date. We are looking forward to recruit more in the future. Any person with a history of 2 or more melanomas, 1 melanoma and positive family history or dysplastic nevus syndrome is welcome to participate in the trial. Our experience so far has been very …
Over the last few years, our research team has been growing and we have been developing multiple clinical trials such as melanoma, non melanoma skin cancers, psoriasis and hidradenitis suppurativa. As the New Year begins, some of us are sad to say goodbye to the research department as we move on to our new positions …
This is another area of interest in our group: the cutaneous manifestations of acute and chronic Graft versus Host Disease. We have a monthly multidisciplinary clinic with Haematology in the Crown Princess Mary Cancer Centre at Westmead Hospital. The Haematology group is developing a fantastic team of specialists (Respiratory, Endocrinology, Gynaecology, etc) around their clinic. …
From the 8th to the 10th of December, A/Prof. Pablo Fernandez-Peñas was the main speaker at the “The ABC of Research” Workshop (Medical Academies of Malaysia, Kuala Lumpur, Malaysia). Roshida Baba (Senior Consultant Dermatologist & Head of Dermatology Services Ministry of Health, Malaysia) was the chair and the soul of the event that was supported …
